前列腺癌患者对临床医生主导的胚系遗传咨询的满意度
该前瞻性研究纳入275例符合国家综合癌症网络(NCCN)遗传检测标准的前列腺癌患者,由泌尿外科或肿瘤内科医生在常规诊疗中提供检测前遗传咨询。98%的患者对咨询整体质量满意,74%的患者选择接受遗传检测,作者认为经培训后该模式可扩大胚系遗传检测的可及性。
要点
- 275例前列腺癌患者中,203例选择接受遗传检测,占74%。
- 265例完成咨询后调查,98%对检测前咨询整体质量满意。
- 作者认为经临床医生培训后,该模式可扩大胚系遗传检测的可及性。
核心结论
- 结果支持临床医生主导的遗传咨询在前列腺癌中的有效性;经临床医生培训后,该方法可用于扩大适当胚系遗传检测的可及性。
研究设计与样本
- 前瞻性实施与评估研究,纳入275例符合NCCN遗传检测考虑标准(转移性或局限性)的前列腺癌患者,由泌尿外科或肿瘤内科医生在常规诊疗中提供检测前遗传咨询并同期邀请入组胚系遗传学研究。
主要发现
- 275例患者入组,203例选择接受遗传检测。
- 265例完成咨询后调查,98%报告对检测前咨询整体质量满意。
- 132例完成遗传检测结果披露后调查。
关键数值与推荐
- 主要结局为接受检测的患者比例,目标为>60%;实际203/275例(74%)选择接受检测。
- 次要结局为对咨询的总体满意度,目标为>85%;实际265例中98%报告满意。
- 患者需符合NCCN遗传检测考虑标准(转移性或局限性前列腺癌)。
临床怎么用
- 由泌尿外科或肿瘤内科医生在常规诊疗中提供检测前遗传咨询,并同期邀请患者入组研究。
- 作者认为经临床医生培训后,该模式可用于扩大适当胚系遗传检测的可及性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Indications for germline testing in prostate cancer patients have expanded substantially over the past decade. With a near-universal shortage of genetic counselors and increasing demand, increased access to genetic counseling is crucial. We sought to prospectively implement and assess a clinician-led approach to genetic counseling and testing. MATERIALS AND METHODS: Patients with metastatic or localized prostate cancer meeting National Comprehensive Cancer Network® criteria for consideration of genetic testing were offered pre-test genetic counseling by their urologist or medical oncologist as part of their routine clinical care and concurrently approached for enrollment in the Germline Genetics in Prostate Cancer Study. Consented patients filled out a post-counseling survey using validated instruments to assess the quality of counseling. For patients who elected to undergo genetic testing, an additional validated questionnaire was completed following disclosure of results. The primary outcome was the proportion of patients undergoing testing, with a target >60% of patients. The secondary outcome was overall satisfaction with counseling, with a target >85% of patients. RESULTS: A total of 275 patients enrolled, and 203 patients elected to undergo genetic testing. Post-counseling surveys were obtained from 265 patients, and post-genetic testing surveys were obtained from 132 patients. Patient satisfaction was high, with 98% of patients reporting being satisfied with the overall quality of pre-test counseling, and 74% of patients elected to undergo genetic testing. CONCLUSIONS: These results support the effectiveness of clinician-led genetic counseling in prostate cancer. With clinician training, this approach can be utilized to expand access to appropriate germline genetic testing.
引用
- Abusamra SM, Solorzano MA, Luke M, et al. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer. J Urol. 2022. PMID: 35930793. doi:10.1097/JU.0000000000002865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。